Using biological markers — genetic characteristics that are associated with some patients with breast cancer — can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research.
Using biological markers — genetic characteristics that are associated with some patients with breast cancer — can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research.